Eikon Therapeutics Inc. (EIKN)
NasdaqGS: EIKN
· リアルタイム株価 · USD
10.98
-0.54 (-4.69%)
終値時点： Aug 28, 2026, 3:59 PM
10.98
+0.00%
時間外: 7:30 PM
株価、主要な数字、最新ニュースをひとまとめにしたページです。
Eikon Therapeutics Inc.（EIKN）の株価・分析・データ
-4.69% (1D)
EIKNについて
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brai...
企業情報の全文決算サプライズ
Eikon TherapeuticsはAug 13, 2026に四半期決算を発表しました：
- 売上高は $0 で、予想を下回りました $0, うち NaN% の前年比増加にあたります.
- EPSは -1.63 で、予想を下回りました -0.17, うち -Infinity% の前年比減少.
